| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2023 ( Subtotal = $7,027,897 ) |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01HL147311 | The role of ciliary melanin-concentrating hormone receptors in Alzheimer's disease | 001 | 4 | NIH | 6/13/2023 | $381,500 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R03AI168826 | Mechanisms and In Vivo Activity of a Next Generation Daptomycin Antibiotic | 000 | 1 | NIH | 11/4/2022 | $69,000 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA239590 | Identifying susceptibility factors for KSHV infection in human tonsil | 001 | 5 | NIH | 3/17/2023 | $6,983 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA239590 | Identifying susceptibility factors for KSHV infection in human tonsil | 000 | 5 | NIH | 3/7/2023 | $342,140 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01HL147311 | The role of ciliary melanin-concentrating hormone receptors in Alzheimer's disease | 000 | 4 | NIH | 5/23/2023 | $345,000 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA264913 | Defining the role of plasma cells in the establishment of KSHV infection in human tonsil | 000 | 3 | NIH | 8/18/2023 | $345,000 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | K01DK125448 | The Role of Thyroglobulin in Thyroid Hormone Synthesis | 002 | 3 | NIH | 7/18/2023 | $38,538 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R03TR004248 | A precision medicine approach to identify walking phenotypes and rehabilitation targets after injury | 002 | 3 | NIH | 4/19/2023 | $68,400 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG054442 | Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | 001 | 4 | NIH | 6/28/2023 | $3,316,214 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01EY034672 | Role of Macrophages in ocular GVHD | 000 | 1 | NIH | 1/27/2023 | $342,000 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R03HD107630 | Determining the effects of increased demands for voluntary adjustments on the neuromuscular control of walking post-stroke | 000 | 1 | NIH | 5/15/2023 | $136,800 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R03HD107630 | Determining the effects of increased demands for voluntary adjustments on the neuromuscular control of walking post-stroke | 001 | 1 | NIH | 5/19/2023 | $14,757 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R15HD110941 | AI-based Fall-Risk Assessment during Daily Activities in Post Stroke Survivors using Smartphones | 000 | 1 | NIH | 5/15/2023 | $391,253 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01HL166175 | Positive Affect and Pediatric Asthma: An Innovative Positive Psychology Model to Improve Asthma Management and Health | 000 | 1 | NIH | 8/30/2023 | $660,090 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | K01MD018417 | Social and Environmental Determinants of Breast Cancer Survivorship: The Black Breast Cancer Survivors Intervention | 001 | 1 | NIH | 6/22/2023 | $0 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | K01MD018417 | Social and Environmental Determinants of Breast Cancer Survivorship: The Black Breast Cancer Survivors Intervention | 000 | 1 | NIH | 6/9/2023 | $124,114 |
| 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG062840 | A Brain Penetrating Bi-functional Transferrin Receptor Antibody-TNF-alpha Decoy Receptor Fusion Protein for Alzheimer's Disease | 001 | 5 | NIH | 4/26/2023 | $377,708 |
| 2023 | 2022 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R03TR004248 | A precision medicine approach to identify walking phenotypes and rehabilitation targets after injury | 001 | 2 | NIH | 12/20/2022 | $68,400 |
| 2023 | 2022 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG054442 | Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | 000 | 3 | NIH | 6/26/2023 | $0 |
| 2023 | 2022 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG062840 | A Brain Penetrating Bi-functional Transferrin Receptor Antibody-TNF-alpha Decoy Receptor Fusion Protein for Alzheimer's Disease | 000 | 4 | NIH | 3/16/2023 | $0 |
| 2023 | 2021 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R33NS101182 | Development of SK channel modulators as therapeutic agents for ataxia | 001 | 3 | NIH | 8/21/2023 | $0 |
| 2023 | 2021 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R33NS101182 | Development of SK channel modulators as therapeutic agents for ataxia | 002 | 3 | NIH | 8/25/2023 | $0 |
| 2023 | 2021 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R33NS101182 | Development of SK channel modulators as therapeutic agents for ataxia | 000 | 3 | NIH | 12/22/2022 | $0 |
| 2023 | 2021 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R00AG055699 | Neighborhood adversity and sensitivity to stress: a study of gene x environment interactions. | 000 | 5 | NIH | 5/5/2023 | $0 |
| 2023 | 2019 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01GM107094 | Molecular signal transduction of cAMP compartments | 001 | 6 | NIH | 1/4/2023 | $90,289 |
| 2023 | 2018 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01GM107094 | Molecular signal transduction of cAMP compartments | 000 | 5 | NIH | 1/4/2023 | -$90,289 |
|
 | Issue Date FY: 2022 ( Subtotal = $5,270,912 ) (Continued on the next page) |
| 2022 | 2022 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA264913 | Defining the role of plasma cells in the establishment of KSHV infection in human tonsil | 000 | 2 | NIH | 8/14/2022 | $345,000 |
| 2022 | 2022 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | K01HD092612 | The influence of brain organization and postural behavior on progression of back pain symptoms in young adults. | 000 | 5 | NIH | 6/27/2022 | $119,135 |
| 2022 | 2022 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA239590 | Identifying susceptibility factors for KSHV infection in human tonsil | 000 | 4 | NIH | 3/23/2022 | $287,488 |
| 2022 | 2022 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA239590 | Identifying susceptibility factors for KSHV infection in human tonsil | 001 | 4 | NIH | 3/30/2022 | $31,943 |
| 2022 | 2022 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA239590 | Identifying susceptibility factors for KSHV infection in human tonsil | 002 | 4 | NIH | 7/28/2022 | $29,808 |
| 2022 | 2022 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG062840 | A Brain Penetrating Bi-functional Transferrin Receptor Antibody-TNF-alpha Decoy Receptor Fusion Protein for Alzheimer's Disease | 003 | 4 | NIH | 4/28/2022 | $377,708 |
| 2022 | 2022 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01GM107094 | Molecular signal transduction of cAMP compartments | 000 | 9 | NIH | 7/18/2022 | $300,426 |
| 2022 | 2022 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG054442 | Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | 000 | 3 | NIH | 8/11/2022 | $3,199,665 |
| 2022 | 2022 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG054442 | Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | 001 | 3 | NIH | 8/16/2022 | $0 |
| 2022 | 2022 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01HL147311 | The role of ciliary melanin-concentrating hormone receptors in Alzheimer's disease | 000 | 3 | NIH | 6/16/2022 | $345,000 |
| 2022 | 2021 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG062840 | A Brain Penetrating Bi-functional Transferrin Receptor Antibody-TNF-alpha Decoy Receptor Fusion Protein for Alzheimer's Disease | 002 | 3 | NIH | 2/28/2022 | $234,733 |
| 2022 | 2020 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | RF1AG054442 | Brain atrophy, cognitive impairment and Alzheimer's in low CVD-risk population | 005 | 2 | NIH | 5/10/2022 | $0 |
| 2022 | 2020 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | RF1AG054442 | Brain atrophy, cognitive impairment and Alzheimer's in low CVD-risk population | 004 | 2 | NIH | 5/10/2022 | $0 |
| 2022 | 2020 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | RF1AG054442 | Brain atrophy, cognitive impairment and Alzheimer's in low CVD-risk population | 006 | 2 | NIH | 5/10/2022 | $0 |
| 2022 | 2019 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01GM107094 | Molecular signal transduction of cAMP compartments | 002 | 6 | NIH | 9/21/2022 | -$90,283 |
| 2022 | 2019 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R00DE024969 | Factors Influencing KSHV Infection and Spread within the Oral Cavity | 002 | 5 | NIH | 6/29/2022 | -$36 |
| 2022 | 2019 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R21NS101182 | Development of SK channel modulators as therapeutic agents for ataxia | 000 | 2 | NIH | 9/26/2022 | $6 |
| 2022 | 2018 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | RF1AG054442 | Brain atrophy, cognitive impairment and Alzheimer's in low CVD-risk population | 003 | 2 | NIH | 5/10/2022 | $0 |
| 2022 | 2018 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | RF1AG054442 | Brain atrophy, cognitive impairment and Alzheimer's in low CVD-risk population | 002 | 2 | NIH | 5/10/2022 | $0 |
| 2022 | 2018 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R00DE024969 | Factors Influencing KSHV Infection and Spread within the Oral Cavity | 001 | 4 | NIH | 6/29/2022 | $0 |
| 2022 | 2018 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01GM107094 | Molecular signal transduction of cAMP compartments | 001 | 5 | NIH | 9/21/2022 | $90,283 |
| 2022 | 2017 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | RF1AG054442 | Brain atrophy, cognitive impairment and Alzheimer's in low CVD-risk population | 000 | 2 | NIH | 5/3/2022 | $0 |
|